Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01052441 · ClinicalTrials.gov registry record
Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Undergoing Cardiac Computed Tomography (CT) Scanning
A clinical trial, sponsored by MDDX.
- Completed
- Registry status
- 250
- Enrollment target
NCT01052441 is a clinical trial that has completed, run by MDDX. The registered enrollment target is 250 participants.
The verdict
NCT01052441 has completed, sponsored by MDDX.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate diagnostic performance of high iodine (iopamidol 370 mg/dl) content versus low iodine (iodixanol 300 mg/dl) content for diagnostic accuracy by contrast-enhanced Coronary Cardiac Computed Tomography (CCTA) using a 64-detector-row CT scanner for detection of presence or absence of coronary artery obstruction when compared against invasive coronary angiography, the standard of truth.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2010-01 |
| Est. Completion | 2012-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01052441
The ClinicalTrials.gov registry entry for NCT01052441 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MDDX, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01052441 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01052441 about?
NCT01052441 is a clinical study titled "Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Undergoing Cardiac Computed Tomography (CT) Scanning". The purpose of the study is to evaluate diagnostic performance of high iodine (iopamidol 370 mg/dl) content versus low iodine (iodixanol 300 mg/dl) content for diagnostic accuracy by contrast-enhanced Coronary Cardiac Computed Tomography (CCTA) using a 64-detector-row CT scanner for detection of pre...
What is the current status of trial NCT01052441?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2010-01. Estimated completion is 2012-09.
Who is sponsoring clinical trial NCT01052441?
This trial is sponsored by MDDX, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.